ANTICOV: Clinical trial for COVID-19 in low-resource settings to test a new combination treatment
The ANTICOV platform clinical trial has started the recruitment of participants to test a new promising drug combination, fluoxetine and budesonide, as an early treatment for people affected with mild-to-moderate COVID-19.